CADL
Price
$8.79
Change
+$0.37 (+4.39%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
617.67M
77 days until earnings call
Intraday BUY SELL Signals
CRBU
Price
$2.00
Change
-$0.31 (-13.36%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
230.59M
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs CRBU

Header iconCADL vs CRBU Comparison
Open Charts CADL vs CRBUBanner chart's image
CADL vs CRBU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CADL vs. CRBU commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongBuy and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (CADL: $8.43 vs. CRBU: $2.33)
Brand notoriety: CADL and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 89% vs. CRBU: 109%
Market capitalization -- CADL: $617.67M vs. CRBU: $230.59M
CADL [@Biotechnology] is valued at $617.67M. CRBU’s [@Biotechnology] market capitalization is $230.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 7 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 5 bearish.
  • CRBU’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +6.04% price change this week, while CRBU (@Biotechnology) price change was +7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

CADL is expected to report earnings on Aug 19, 2026.

CRBU is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($618M) has a higher market cap than CRBU($231M). CADL YTD gains are higher at: 49.204 vs. CRBU (46.226). CADL has higher annual earnings (EBITDA): -50.3M vs. CRBU (-116.43M). CADL has more cash in the bank: 195M vs. CRBU (118M). CRBU has less debt than CADL: CRBU (26.9M) vs CADL (49.3M). CRBU has higher revenues than CADL: CRBU (11.2M) vs CADL (0).
CADLCRBUCADL / CRBU
Capitalization618M231M268%
EBITDA-50.3M-116.43M43%
Gain YTD49.20446.226106%
P/E RatioN/AN/A-
Revenue011.2M-
Total Cash195M118M165%
Total Debt49.3M26.9M183%
TECHNICAL ANALYSIS
Technical Analysis
CADLCRBU
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCICX10.680.02
+0.19%
BlackRock Multi-Asset Income Investor C
IVFCX4.70N/A
N/A
Federated Hermes Intl Strat Val Div C
OSMNX32.52N/A
N/A
Invesco International Small-Mid Com R
NMVZX13.11N/A
N/A
Nuance Mid Cap Value Z
GCEDX14.10N/A
N/A
Goldman Sachs Clean Energy Income Ins

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-0.94%
AURA - CADL
47%
Loosely correlated
-3.96%
RXRX - CADL
43%
Loosely correlated
-4.62%
CRBU - CADL
43%
Loosely correlated
-4.32%
MGX - CADL
41%
Loosely correlated
+1.53%
NKTX - CADL
40%
Loosely correlated
-7.32%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-4.32%
EDIT - CRBU
64%
Loosely correlated
-15.72%
CRSP - CRBU
59%
Loosely correlated
-4.00%
RXRX - CRBU
56%
Loosely correlated
-4.62%
SANA - CRBU
53%
Loosely correlated
+0.78%
BEAM - CRBU
53%
Loosely correlated
-7.00%
More